MedPath

湖南泰阳药业有限公司

Ownership
-
Established
2004-03-10
Employees
-
Market Cap
-
Website
hntaiyangyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

NMPA:10

Drug Approvals

舒筋风湿酒

Approval Number
国药准字Z20026388
Approval Date
Feb 5, 2024
NMPA

复方天麻益阴酒

Approval Number
国药准字Z20025890
Approval Date
Feb 5, 2024
NMPA

三蛇药酒

Approval Number
国药准字Z43020094
Approval Date
Feb 5, 2024
NMPA

三鞭酒

Approval Number
国药准字Z43020090
Approval Date
Feb 5, 2024
NMPA

雪上花搽剂

Approval Number
国药准字Z20020138
Approval Date
Feb 5, 2024
NMPA

风湿酒

Approval Number
国药准字Z43020089
Approval Date
Feb 5, 2024
NMPA

藿香正气水

Approval Number
国药准字Z43020087
Approval Date
Feb 5, 2024
NMPA

复方益肝灵胶囊

Approval Number
国药准字Z20173026
Approval Date
Apr 15, 2022
NMPA

脑乐静

Approval Number
国药准字Z43020086
Approval Date
Jul 10, 2002
NMPA

养血当归糖浆

Approval Number
国药准字Z43020095
Approval Date
Jul 10, 2002
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.